Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Genelux (GNLX) EBIT (2022 - 2025)

Genelux has reported EBIT over the past 4 years, most recently at -$9.4 million for Q4 2025.

  • Quarterly results put EBIT at -$9.4 million for Q4 2025, up 3.45% from a year ago — trailing twelve months through Dec 2025 was -$35.1 million (down 10.88% YoY), and the annual figure for FY2025 was -$33.2 million, down 4.79%.
  • EBIT for Q4 2025 was -$9.4 million at Genelux, down from -$8.2 million in the prior quarter.
  • Over the last five years, EBIT for GNLX hit a ceiling of $6.3 million in Q3 2022 and a floor of -$9.7 million in Q4 2024.
  • Median EBIT over the past 4 years was -$6.9 million (2024), compared with a mean of -$6.0 million.
  • Biggest five-year swings in EBIT: tumbled 183.65% in 2023 and later increased 3.45% in 2025.
  • Genelux's EBIT stood at -$3.1 million in 2022, then tumbled by 126.28% to -$7.0 million in 2023, then plummeted by 39.24% to -$9.7 million in 2024, then increased by 3.45% to -$9.4 million in 2025.
  • The last three reported values for EBIT were -$9.4 million (Q4 2025), -$8.2 million (Q3 2025), and -$7.8 million (Q2 2025) per Business Quant data.